Effect of major histocompatibility disparity on mycophenolate mofetil immunosuppression in rat pancreas transplantation.
Department of Surgery, Case Western Reserve University, Cleveland, Ohio, USA.
J A
JA
Schulak
V
V
Krishnamurthi
R
R
Masih
A
A
Robinson
D000818:Animals; D000961:Antilymphocyte Serum; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation / Q000276:immunology; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D008285:Major Histocompatibility Complex; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D016035:Pancreas Transplantation / Q000276:immunology*; D051381:Rats; D011915:Rats, Inbred BUF; D011917:Rats, Inbred Lew; D013997:Time Factors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid